RGT 17.7% 30.0¢ argent biopharma limited

MXC Pros and Cons, page-2

  1. 2,143 Posts.
    lightbulb Created with Sketch. 235
    Here is some of the con's:
    Correct me if I'm wrong
    The founder and financier of the project has never been able to get any of his companies he has been involved with off the ground, in fact the last 2
    DCC and CTR are in deep trouble.
    The Israeli founders have not much experience in medical marijuana and as far as I can see not much success in anything else either
    The Czech panax deal is a science experiment with MGC getting the by products of testing?
    The crop to be harvested in Q4 is going to be used for cosmetic purposes not medical uses, which makes it as useful only if you can sell the cosmetic product?
    At this present time MXC is nothing more than a cosmetic company and not a very successful one at that?

    You are betting against a lot of odds hinging on law changes and licence grants and pimply teens buying enough product to justify the MC

    All IMO of course!
    Last edited by delux73: 26/08/16
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.045(17.7%)
Mkt cap ! $13.58M
Open High Low Value Volume
25.5¢ 30.0¢ 25.5¢ $1.492K 5.713K

Buyers (Bids)

No. Vol. Price($)
1 1292 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 5 1
View Market Depth
Last trade - 15.36pm 27/06/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.